Meta-analysis of 25 studies (9 RCTs, 16 observational; 81,992 patients) in cirrhosis: statins were linked to lower all-cause mortality overall (OR 0.59) and in RCTs (OR 0.45); lower decompensation was seen overall (OR 0.56) but not in RCTs (OR 0.75, NS).
Meta-analysisn = 81,992
Moraes et al. Statin Therapy Independently Reduces Mortality and Liver Complications in Patients With Cirrhosis: An Updated Systematic Review and Meta-Analysis